Introduction and Objectives: There is currently conflicting evidence regarding the effectiveness of reverse shoulder arthroplasty (RSA) in the treatment of proximal humeral fractures. Trabecular titanium (TT) is a highly porous biomaterial increasingly adopted in joint arthroplasty, particularly in cases with poor bone stock and compromised bone quality. This study aims to evaluate the effectiveness of TT and the clinical and radiological outcomes in the treatment of complex proximal humeral fractures using RSA as the first choice in elderly patients. We evaluated the differences and advantages of outcomes in the use of TT metaglene compared with standard implants.
TT metaglene has shown good results at short-term follow-up. No relevant major postoperative complications emerged; it may represent a valuable option for functional recovery in elderly patients and for patients with poor bone stock. The TT implant demonstrates superior clinical results compared with the standard implant.
Level of evidence: III. Copyright remains with the authors and publisher.
Introduction and Objectives: There is currently conflicting evidence regarding the effectiveness of reverse shoulder arthroplasty (RSA) in the treatment of proximal humeral fractures. Trabecular titanium (TT) is a highly porous biomaterial increasingly adopted in joint arthroplasty, particularly in cases with poor bone stock and compromised bone quality. This study aims to evaluate the effectiveness of TT and the clinical and radiological outcomes in the treatment of complex proximal humeral fractures using RSA as the first choice in elderly patients. We evaluated the differences and advantages of outcomes in the use of TT metaglene compared with standard implants.
TT metaglene has shown good results at short-term follow-up. No relevant major postoperative complications emerged; it may represent a valuable option for functional recovery in elderly patients and for patients with poor bone stock. The TT implant demonstrates superior clinical results compared with the standard implant.
Level of evidence: III. Copyright remains with the authors and publisher.